Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection.
about
Management of psoriasis patients with hepatitis B or hepatitis C virus infectionTreatment of rheumatic diseases and hepatitis B virus coinfectionDiscontinuation of antiviral prophylaxis correlates with high prevalence of hepatitis B virus (HBV) reactivation in rheumatoid arthritis patients with HBV carrier state: a real-world clinical practice.Safety and efficacy of anti-tumor necrosis factors α in patients with psoriasis and chronic hepatitis CPrevalence of past and reactivated viral infections and efficacy of cyclosporine A as monotherapy or in combination in patients with psoriatic arthritis--synergy study: a longitudinal observational study.Assessing the safety of biologic agents in patients with rheumatoid arthritis.An update on the management of hepatitis C virus-related arthritis.Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection.The Use of Cyclosporine A in Rheumatology: a 2016 Comprehensive Review.Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients.Efficacy and safety of anti-TNF-alpha therapy combined with cyclosporine A in patients with rheumatoid arthritis and concomitant hepatitis C virus infection.Treatment of psoriasis in patients with hepatitis C virus infection.
P2860
Q28078157-6E0B04DB-6C70-48B7-88E4-4CCA77C85F9FQ28084305-94E13AA3-14CA-427B-87D9-17C5F09B12EAQ35060142-AB21A44C-187E-4D40-BE52-B757A99ACB28Q36522235-76D61858-DF3E-4E4A-A2F0-0CDAA6180DB6Q37717810-DB24C2BE-8DCF-4DEC-88F9-A56B708CAF89Q38020463-A17D1E88-5B17-4ECA-A462-DD7894F96262Q38242116-E5F6D3F6-04B5-43F9-A52C-7222508397B1Q38344512-E2031E25-D243-46C7-A7F6-E3284FD7DBF6Q38925320-412BE8A5-12D9-4412-94DF-77B327BE03B9Q42274394-8BE61BFC-DEBC-4F6E-8E9A-47A3E60A706EQ42988478-4107E60C-6432-4A6A-83A5-54D9F8BDDC30Q44807883-7EF5429B-EA24-44D2-82B9-DF95691F4059
P2860
Safety of cyclosporin A in HCV-infected patients: experience with cyclosporin A in patients affected by rheumatological disorders and concomitant HCV infection.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Safety of cyclosporin A in HCV ...... and concomitant HCV infection.
@en
type
label
Safety of cyclosporin A in HCV ...... and concomitant HCV infection.
@en
prefLabel
Safety of cyclosporin A in HCV ...... and concomitant HCV infection.
@en
P2093
P2860
P356
P1476
Safety of cyclosporin A in HCV ...... and concomitant HCV infection.
@en
P2093
Chiara Giannitti
Francesca Bellisai
Gabriella Morozzi
Gian Domenico Sebastiani
Stefania Manganelli
P2860
P304
P356
10.1196/ANNALS.1423.058
P407
P577
2007-09-01T00:00:00Z